Should rapid antigen tests be used as a screening…
For any questions or information, please email: covidrapidreviewteam@gmail.com.
RAgT_SR_22Aug2020_V4 FinalFor any questions or information, please email: covidrapidreviewteam@gmail.com.
RAgT_SR_22Aug2020_V4 FinalFor any questions or information, please email covidrapidreviewteam@gmail.com.
Facemask pedia Abridged 15JuneHere is the Department of Health criteria for the discharge and recovery of COVID-19 patients.
> NOTE: The COVID-19 Living Clinical Practice Guidelines contains UPDATED recommendations and evidence summaries. Click here to be redirected to the COVID LCPG.
This Interim Guidance on the Clinical Management of Adult Patients with Suspected or Confirmed COVID-19 Infection (Version 3.1) is an update of the March 31, 2020 guidelines released by the Philippine Society for Microbiology and Infectious Diseases. New evidence have been published since then necessitating this update.This document is written to guide clinicians and health care workers in their COVID-19 related management decisions. It is based on available scientific evidence that is also rapidly evolving, as more is discovered about the pathophysiology of SARS CoV-2 and the pathogenesis of the disease. As such, the recommendations in this guideline are based on limited, often low-quality evidence, and need to be carefully balanced with clinical judgment. The use of investigational drugs should be discussed with the patient or a legally authorized representative carefully outlining the potential adverse reactions and the potential clinical benefits of these investigational drugs. A signed informed consent should be obtained by the clinician.
DOWNLOAD the Interim Management Guidelines for COVID-19 (Version 3.1) here.
The performance of surgeries, especially elective surgeries, has been affected as healthcare facilities responded to the COVID-19 pandemic. However, surgery and other interventional procedures are invaluable aspects of healthcare even during disasters, mass casualty incidents, and even during pandemics. An organized and well-planned approach is needed to protect healthcare workers performing surgery and to rationally use available PPEs.
This document aims to provide guidance on how to assess the risk of COVID-19 transmission to the surgical team and recommend the necessary PPE to be used for every scenario. This is intended for surgeons, infectious disease specialists, internists and other physicians who will perform procedures or evaluate patients prior to such procedures. Other personnel involved in the surgical team might also find this document useful. Optimizing operating room infrastructure and other infection prevention and control measures are not within the scope of this document. Recommendations from this document may change as new evidence becomes available.
DOWNLOAD the Risk Assessment of Surgeries in the Context of COVID-19 document here.
PSMID-PHICS Guidelines for Risk Assessment of Surgeries during COVID19 26May2020It has been 4 months and healthcare workers start to burn out. Many healthcare workers get sick, and no life is worth one million pesos. We are not superheroes. We are not immune to the virus. As a matter of fact, many healthcare workers (like nurses) opt to resign because of the risks in their lives without proper compensation. Yes, it is our duty to take care of the sick, but we have lives and families of our own to protect. When we get infected, it should not be always blamed on breech in PPE protocols. Are PPEs provided appropriate and of good quality? We have been reusing, extending use, or improvising PPEs. Many private hospitals are on the verge of bankruptcy.
In some provinces, there are only one or two IDS specialists, in others, none. We have felt the surge of cases the past month and believe me when I say that lately patients are more critical and we see more morbidities and mortalities even among the young ones, and sometimes even among our colleagues in the medical field. Aside from managing COVID patients, we continuously monitor the implementation of Infection Prevention and Control measures in our institutions, we coordinate patients to the Regional and City Health Surveillance Units, and we attend to numerous meetings with the hospital administration on how to better cater to our COVID patients. The Infectious Diseases Specialists, just like all frontliners, are spread out too thin. This is not just about physical exhaustion; it also takes a toll on our emotional and psychological wellness. But let me affirm our commitment to serve as health care workers. We are one with the country in the fight against COVID-19.
We call for the solidarity of all stakeholders and the cooperation of each and every Filipino. This war against COVID is not just in the hospital level; it starts in each one of us, in each household, and in each community. Therefore, we appeal to the public to strictly adhere to preventive measures such as physical distancing, hand hygiene, and wearing of masks and face shields. Cliché as it seems but prevention is key to saving lives.
Now more than ever, the Philippine Society for Microbiology and Infectious Diseases, together with the Philippine College of Physicians, remain committed to serving the Filipino people especially during this public health emergency of international concern. We remain dedicated to saving lives and reducing the burden of infectious diseases in the country. We urgently need health care reform for better health in the community.
For any questions or information, please email covidrapidreviewteam@gmail.com.
Steam Inhalation for COVID Full Report 14JUL2020 V1 TU MM SA EU LFDFor any questions or information, please email covidrapidreviewteam@gmail.com.
Closed Suctioning Abridged 25June2020 V1.0Here is the latest treatment algorithm for the management of patients with probable or confirmed COVID-19.
Updated_COVID tx algorithm_July 20The Interim Management Guidelines for COVID-19 (Version 3.1) can be accessed here.
For any questions or information, please email: covidrapidreviewteam@gmail.com.
SCHOOL CLOSURE ABRIDGED June 27 FINALDr. Jemelyn Garcia, FPCP, FPSMID
Dr. Maria Sonia Salamat, FPCP, FPSMID
Dr. Marja B. Buensalido, FPCP, FPSMID
Dr. Emmerson Gale Vista, FPDS
Dr. Clarisse Garcia-Mendoza, FPDS
Dr. Kingbherly L. Li, FPCP, FPSMID
Dr. Yvette Silubrico, FPCP, FPSMID
Dr. Chatie Olasiman, FPCP, FPSMID
Dr. Ma. Charmian Hufano, FPCP, FPSMID
Dr. Mitzie Lou Osabel, FPCP, FPSMID
Dr. Janice C. Caoili, FPCP, FPSMID
The Philippine Society for Microbiology and Infectious Diseases (PSMID) Guidance on the Management of Mpox, Ver. 1 provides the basic and most updated information on management of patients confirmed with mpox.
This guidance complements the mpox recommendations of the DOH (Updated Interim Guidelines on the Prevention, Detection, and Management of MPOX, by Department of Health, August 26, 2024, Department Memorandum 2024-0306) and PHICS-PHICNA (Interim Guidelines on the Prevention and Control of Monkeypox version 1).
The antivirals, immunoglobulin and vaccines discussed below are not available locally. In our local situation, we should maximize supportive care for mpox cases.